Animal Shared Resource
Animal Shared Resource
批准号:
10360634
负责人:
Jessie Villanueva
金额:
$24.17万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-04-01 至 2024-02-29
关键词:
AccreditationAnimal ModelAnimalsAreaBasic Cancer ResearchBiometryBreedingCancer CenterCancer Research ProjectCapitalCaringCollaborationsContainmentDoctor of Veterinary MedicineEmployeeEquipment and supply inventoriesFacultyFingerprintFox Chase Cancer CenterGenerationsHealthHealth Services AccessibilityHousingIACUCImmunodeficient MouseIndividualIndustry StandardInternationalInvestmentsLaboratory Animal MedicineMissionMonitorMusPathologistPlayProceduresProtocols documentationQuarantineResearchResearch PersonnelResource SharingResourcesRoleScanningScientific Advances and AccomplishmentsSecurityServicesSterilitySystemThe Wistar InstituteTimeTrainingTraining TechnicsTransgenic Mouse FacilityTransgenic OrganismsX-Ray Computed Tomographyanimal careanimal facilityflexibilityimaging systemin vivo imagingin vivo imaging systeminter-institutionalmembermultidisciplinaryoperationprogramsrecruit
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY – ANIMAL SHARED RESOURCE
The Wistar Cancer Center operates an AAALAC—accredited Animal Shared Resource (ASR) serving faculty
from all three scientific Programs. Expert management, husbandry, custodial and veterinary staff maintain the
ASR, including a modified Biosafety Level 2 (BSL2) barrier, with the following specific aims:
· Provide service in laboratory animal medicine and husbandry, routine animal procurement, animal health
surveillance, veterinary care, inventory monitoring, quarantine housing, routine technical support and
technical training for all Cancer Center investigators using animals in their research.
· Maintain an NSG (NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ) breeding colony for the generation of immunodeficient
mice.
· Provide access to expertise for the generation of transgenic and genetically modified mice through our inter-
institutional collaboration with the transgenic mouse facility at Fox Chase Cancer Center.
· Provide access to the services of a full time veterinary pathologist, David Garlick, D.V.M.
· Administer Institutional Animal Care and Use Committee (IACUC) mandated new employee orientation and
IACUC procedures training as well as aseptic technique training for new researchers.
· House a suite for in vivo imaging, including a PerkinElmer IVIS Spectrum µCT Imaging System.
Construction was completed, and the new, state-of-the-art vivarium opened in November 2013. Equipped with
rack space to house more than 6,000 sterile, disposable, and individually-ventilated mouse cages, the brand
new, 13,570 NSF, vivarium employs technologically-advanced, disposable, and individually-ventilated cages
supported by a new HVAC system. Since 2013, an institutional investment of more than $14 million has been
allocated to the ASR to fulfill the mission and research objectives of the Cancer Center (CC). This significant
capital allocation allowed for the construction and fit-out of the new vivarium, including features which enhance
all areas of animal care for Cancer Center investigators. Access controls include ID card swipe, biometric
fingerprint scan, and security cameras. Holding rooms are equipped with new ventilated racks. Further
investments include isolation cubicles, which are species independent and allow for maximum flexibility while
providing the industry standard for containment and isolation. During the project period, the recruitment of 10
new CC members has driven a 47% increase in the use of murine animal models. An additional animal
caretaker was hired in 2016 to meet the increasing demand for services. To streamline day-to-day operations
of the ASR, a new IACUC protocol and Animal Facility Management system is being incorporated in 2018.
Together, the ASR continues to play an essential role to support the scientific portfolio of all three Programs in
the Cancer Center, tangibly contributing to key multidisciplinary scientific advances.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting S6K2 to Overcome Drug Resistance in NRAS-mutant Melanoma
-
批准号:10539830
-
项目类别:
-
资助金额:$52.28万
-
财政年份:2022
-
负责人:Jessie Villanueva
-
依托单位:
Career Enhancement Program
-
批准号:10480867
-
项目类别:
-
资助金额:$8.84万
-
财政年份:2021
-
负责人:Jessie Villanueva
-
依托单位:
Career Enhancement Program
-
批准号:10268748
-
项目类别:
-
资助金额:$8.51万
-
财政年份:2021
-
负责人:Jessie Villanueva
-
依托单位:
Targeting TERT in Melanoma
-
批准号:10247101
-
项目类别:
-
资助金额:$4.9万
-
财政年份:2017
-
负责人:Jessie Villanueva
-
依托单位:
Administrative Core
-
批准号:10733193
-
项目类别:
-
资助金额:$7.92万
-
财政年份:2017
-
负责人:Jessie Villanueva
-
依托单位:
Functional precision approaches to overcome intrinsic and acquired drug resistance in melanoma
-
批准号:10733196
-
项目类别:
-
资助金额:$25.58万
-
财政年份:2017
-
负责人:Jessie Villanueva
-
依托单位:
Molecular approaches to overcome intrinsic drug resistance in BRAF and NRAS-mutan
-
批准号:8634081
-
项目类别:
-
资助金额:$15.08万
-
财政年份:2013
-
负责人:Jessie Villanueva
-
依托单位:
Molecular approaches to overcome intrinsic drug resistance in BRAF and NRAS-mutan
-
批准号:9054086
-
项目类别:
-
资助金额:$15.08万
-
财政年份:2013
-
负责人:Jessie Villanueva
-
依托单位:
Molecular approaches to overcome intrinsic drug resistance in BRAF and NRAS-mutan
-
批准号:8826711
-
项目类别:
-
资助金额:$15.08万
-
财政年份:2013
-
负责人:Jessie Villanueva
-
依托单位:
Molecular approaches to overcome intrinsic drug resistance in BRAF and NRAS-mutan
-
批准号:9246446
-
项目类别:
-
资助金额:$15.08万
-
财政年份:2013
-
负责人:Jessie Villanueva
-
依托单位:
Molecular approaches to overcome intrinsic drug resistance in BRAF and NRAS-mutan
-
批准号:8488046
-
项目类别:
-
资助金额:$15.08万
-
财政年份:2013
-
负责人:Jessie Villanueva
-
依托单位:
Animal Shared Resource
-
批准号:10570933
-
项目类别:
-
资助金额:$24.17万
-
财政年份:1997
-
负责人:Jessie Villanueva
-
依托单位:
Animal Shared Resource
-
批准号:9917704
-
项目类别:
-
资助金额:$22.44万
-
财政年份:--
-
负责人:Jessie Villanueva
-
依托单位:
海外基金